VON RICKENBACH JOSEF H
Director
PurchaseAlert
- Shares
- 4,500
- Price
- $1.07
- Value
- $4,819
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•5 filings
RNTX
Rein Therapeutics, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$202,154
7 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
10
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get RNTX insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
RNTX overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
11
Raw transactions
Everything returned by the filing
10
Voluntary view
P/S trades after deterministic checks
1
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 150,000
- Price
- $0.00
- Footnotes
- 2
Shares purchased in Issuer's April 30, 2026 follow-on public offering. This option was granted on May 8, 2026. The 25% of the shares underlying the option are scheduled to vest on May 8, 2027 and thereafter in equal monthly installments through May 8, 2031.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
VON RICKENBACH JOSEF H
Director
PurchaseAlert
- Shares
- 23,190
- Price
- $1.06
- Value
- $24,470
VON RICKENBACH JOSEF H
Director
PurchaseAlert
- Shares
- 15,950
- Price
- $1.05
- Value
- $16,708
VON RICKENBACH JOSEF H
Director
PurchaseAlert
- Shares
- 3,420
- Price
- $1.04
- Value
- $3,564
WINDSOR JAMES BRIAN
See Remarks
PurchaseAlert
- Shares
- 25,000
- Price
- $1.00
- Value
- $25,000
Voss Capital, LP
10% owner
PurchaseAlert
- Shares
- 104,183
- Price
- $1.22
- Value
- $127,593
Voss Capital, LP
10% owner
PurchaseAlert
- Shares
- 178,392
- Price
- $1.39
- Value
- $247,965
Voss Capital, LP
10% owner
PurchaseAlert
- Shares
- 4,840
- Price
- $1.37
- Value
- $6,625
Voss Capital, LP
10% owner
PurchaseAlert
- Shares
- 92,642
- Price
- $1.37
- Value
- $126,920
Voss Capital, LP
10% owner
PurchaseAlert
- Shares
- 30,176
- Price
- $1.39
- Value
- $41,957
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| May 27, 2026 | VON RICKENBACH JOSEF H Director | Purchase | 4,500 | $1.07 | $4,819 | |
| May 26, 2026 | VON RICKENBACH JOSEF H Director | Purchase | 23,190 | $1.06 | $24,470 | |
| May 22, 2026 | VON RICKENBACH JOSEF H Director | Purchase | 15,950 | $1.05 | $16,708 | |
| May 21, 2026 | VON RICKENBACH JOSEF H Director | Purchase | 3,420 | $1.04 | $3,564 | |
| Apr 30, 2026 | WINDSOR JAMES BRIAN See Remarks | Purchase | 25,000 | $1.00 | $25,000 | |
| Nov 14, 2025 | Voss Capital, LP 10% owner | Purchase | 104,183 | $1.22 | $127,593 | |
| Oct 28, 2025 | Voss Capital, LP 10% owner | Purchase | 178,392 | $1.39 | $247,965 | |
| Oct 27, 2025 | Voss Capital, LP 10% owner | Purchase | 4,840 | $1.37 | $6,625 | |
| Oct 27, 2025 | Voss Capital, LP 10% owner | Purchase | 92,642 | $1.37 | $126,920 | |
| Oct 24, 2025 | Voss Capital, LP 10% owner | Purchase | 30,176 | $1.39 | $41,957 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.